210 related articles for article (PubMed ID: 16253214)
21. Myocardial proteases and cardiac remodeling.
Riaz S; Zeidan A; Mraiche F
J Cell Physiol; 2017 Dec; 232(12):3244-3250. PubMed ID: 28255990
[TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
[TBL] [Abstract][Full Text] [Related]
23. The extracellular connections: the role of integrins in myocardial remodeling.
Ross RS
J Card Fail; 2002 Dec; 8(6 Suppl):S326-31. PubMed ID: 12555140
[TBL] [Abstract][Full Text] [Related]
24. Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.
Wilson EM; Spinale FG
Ann Med; 2001 Dec; 33(9):623-34. PubMed ID: 11817657
[TBL] [Abstract][Full Text] [Related]
25. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
Deschamps AM; Spinale FG
Cardiovasc Res; 2006 Feb; 69(3):666-76. PubMed ID: 16426590
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
[TBL] [Abstract][Full Text] [Related]
27. Integrin expression during reverse remodeling in the myocardium of heart failure patients.
Dullens HF; Schipper ME; van Kuik J; Sohns W; Scheenstra M; van Wichen DF; Van Oosterhout MF; de Jonge N; de Weger RA
Cardiovasc Pathol; 2012; 21(4):291-8. PubMed ID: 22100988
[TBL] [Abstract][Full Text] [Related]
28. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
Vanhoutte D; Schellings M; Pinto Y; Heymans S
Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
[TBL] [Abstract][Full Text] [Related]
29. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
Ushakov A; Ivanchenko V; Gagarina A
Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension.
Takenaka H; Kihara Y; Iwanaga Y; Onozawa Y; Toyokuni S; Kita T
J Mol Cell Cardiol; 2006 Dec; 41(6):989-97. PubMed ID: 16979182
[TBL] [Abstract][Full Text] [Related]
32. Role of CyPA in cardiac hypertrophy and remodeling.
Cao M; Yuan W; Peng M; Mao Z; Zhao Q; Sun X; Yan J
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31825469
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.
Hutchinson KR; Stewart JA; Lucchesi PA
J Mol Cell Cardiol; 2010 Mar; 48(3):564-9. PubMed ID: 19524591
[TBL] [Abstract][Full Text] [Related]
34. [Recent findings on scleral extracellular matrix and matrix metalloproteinases in the development of myopia].
Long Q; Chu RY
Zhonghua Yan Ke Za Zhi; 2005 Nov; 41(11):1047-9. PubMed ID: 16318765
[TBL] [Abstract][Full Text] [Related]
35. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
[TBL] [Abstract][Full Text] [Related]
36. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
[TBL] [Abstract][Full Text] [Related]
37. A look between the cardiomyocytes: the extracellular matrix in heart failure.
Miner EC; Miller WL
Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
[TBL] [Abstract][Full Text] [Related]
38. Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors.
Kassiri Z; Khokha R
Thromb Haemost; 2005 Feb; 93(2):212-9. PubMed ID: 15711735
[TBL] [Abstract][Full Text] [Related]
39. Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.
Patterson NL; Iyer RP; de Castro Brás LE; Li Y; Andrews TG; Aune GJ; Lange RA; Lindsey ML
Proteomics Clin Appl; 2013 Aug; 7(7-8):516-27. PubMed ID: 23532927
[TBL] [Abstract][Full Text] [Related]
40. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes.
Fata JE; Werb Z; Bissell MJ
Breast Cancer Res; 2004; 6(1):1-11. PubMed ID: 14680479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
